A Phase 1 Comparative Study of E2022 Current and New Patch Formulations

NCT02042729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: E2022- Current Formula Tape
DRUG: E2022- New Formula Tape
DRUG: E2022 Matching Placebo- Current Formula Tape
DRUG: E2022 Matching Placebo- New Formula Tape

Sponsor

Eisai Co., Ltd.